Alembic Pharmaceuticals (NSE:APLLTD) Other Current Payables: ₹2,579 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:APLLTD Alembic Pharmaceuticals Ltd NSE:APLLTD
77 GF Score
Price ₹797.60
GF Value ₹1,057.10
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Alembic Pharmaceuticals Other Current Payables?

Alembic Pharmaceuticals NSE:APLLTD -0.09% 77 Other Current Payables is ₹2,579 Mil as of Mar. 2026. GuruFocus rates NSE:APLLTD with a GF Score™ of 77/100 and a GF Value™ of ₹1,057.10 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Alembic Pharmaceuticals's Other Current Payables for the quarter that ended in Mar. 2026 was ₹2,579 Mil.

Alembic Pharmaceuticals's quarterly Other Current Payables stayed the same from Sep. 2025 (₹0 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹2,579 Mil).

Alembic Pharmaceuticals's annual Other Current Payables increased from Mar. 2024 (₹1,766 Mil) to Mar. 2025 (₹1,870 Mil) and increased from Mar. 2025 (₹1,870 Mil) to Mar. 2026 (₹2,579 Mil).

Alembic Pharmaceuticals Other Current Payables Related Terms

Alembic Pharmaceuticals Other Current Payables Historical Data

* Premium members only.

The historical data trend for Alembic Pharmaceuticals's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alembic Pharmaceuticals Other Current Payables Chart

Alembic Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,199.60 1,641.60 1,766.20 1,869.80 2,578.60

Alembic Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,869.80 0.00 0.00 0.00 2,578.60
NSE:APLLTD
77GF Score
Alembic Pharmaceuticals Ltd NSE:APLLTD
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alembic Pharmaceuticals Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of ₹2,579 Mil mean?
Alembic Pharmaceuticals (NSE:APLLTD) has a Other Current Payables of ₹2,579 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Alembic Pharmaceuticals and its competitors.
Is Alembic Pharmaceuticals' Other Current Payables too high?
Alembic Pharmaceuticals' current Other Current Payables is ₹2,579 Mil. Overall, Alembic Pharmaceuticals has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alembic Pharmaceuticals' Other Current Payables compare to ZTS and UTHR?
Alembic Pharmaceuticals' Other Current Payables of ₹2,579 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Drug Manufacturers company?
A good Other Current Payables depends on the Drug Manufacturers industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Alembic Pharmaceuticals and its competitors. Alembic Pharmaceuticals's current Other Current Payables is ₹2,579 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alembic Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Alembic Pharmaceuticals (NSE:APLLTD) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,057.10, compared to a current price of ₹797.60 — trading 24.5% below its estimated fair value. The current Other Current Payables is ₹2,579 Mil. Alembic Pharmaceuticals' overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Alembic Pharmaceuticals (NSE:APLLTD), the current Other Current Payables is ₹2,579 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alembic Pharmaceuticals (NSE:APLLTD) Overvalued in 2026?

Based on GuruFocus' analysis, Alembic Pharmaceuticals stock appears to be undervalued. The current stock price of ₹797.60 is trading 24.5% below its estimated GF Value™ of ₹1,057.10. GuruFocus considers Alembic Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for NSE:APLLTD:

  • Other Current Payables: ₹2,579 Mil
  • GF Value™: ₹1,057.10 vs. price of ₹797.60 (24.5% below fair value)
  • GF Score™: 77/100 with 3 warning signs

No single metric tells the full story. See the NSE:APLLTD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alembic Pharmaceuticals Business Description

Other Exchanges 533573:India
Address Alembic Road, Vadodara, GJ, IND, 390 003
Alembic Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company focuses on manufacturing and marketing generic pharmaceutical products across the globe. Alembic also operates a branded formulation business that covers a range of therapeutic areas such as dermatology, oncology, ophthalmology, and injectable formulations. The company considers merger and acquisition investment as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities.
77GF Score

Get the complete analysis for NSE:APLLTD

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹797.60
Price
₹1,057.10
GF Value